Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia November 2022 22(11):835-840 - Subject
- Language
- ISSN
- 2152-2650